A clot history is a travel-risk issue, not only a surgery issue
NHS information describes deep vein thrombosis as a blood clot in a vein, often in the leg, and pulmonary embolism as a serious complication when a clot travels to the lungs. Hair transplant travel adds long sitting time, flights, reduced movement after surgery and sometimes dehydration. A previous clot should therefore trigger structured pre-travel risk review.
Anticoagulant changes must not be casual
Patients may be taking warfarin, apixaban, rivaroxaban, edoxaban, dabigatran, heparin injections or antiplatelet medicines. Stopping or changing these medicines can increase clot risk, while continuing them can increase bleeding risk. The plan should be documented by the prescribing clinician, GP, haematologist or anticoagulation clinic where appropriate.
When travel should wait
Postponement is sensible after a recent DVT or PE, new clotting diagnosis, unstable INR, recent anticoagulant change, active leg swelling, chest pain, unexplained breathlessness, pending haematology review or if the patient cannot obtain medication instructions. Elective surgery should not outrank clot safety.
Flight-risk controls are part of the pathway
Travel-thrombosis advice commonly focuses on movement, hydration and avoiding prolonged immobility. For a hair transplant patient, this means planning aisle movement where safe, avoiding alcohol dehydration, wearing compression only if advised, organising transport that reduces long waits and avoiding a rushed return flight immediately after a long procedure.
What to send before assessment
Send the clot date, affected site, provoking factor if known, thrombophilia diagnosis, family history, medication name and dose, last INR if on warfarin, haematology advice, flight duration and whether any symptoms are active. The clinic should decide whether the case is suitable now, suitable with clearance, or too risky for travel surgery.